Detalhe da pesquisa
1.
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
J Med Chem
; 50(5): 984-1000, 2007 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-17274610
2.
A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
Diabetes
; 51(5): 1453-60, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11978642
3.
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists.
Bioorg Med Chem Lett
; 17(4): 1056-61, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157013
4.
Indanylacetic acids as PPAR-delta activator insulin sensitizers.
Bioorg Med Chem Lett
; 17(15): 4369-73, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17601734
5.
Substituted indanylacetic acids as PPAR-alpha-gamma activators.
Bioorg Med Chem Lett
; 16(2): 297-301, 2006 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16275080
6.
Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide.
J Biol Chem
; 278(12): 10273-81, 2003 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12525492